Previous | Home | EndoTODAY | List | Next


[Endoscopic diagnosis of Borrmann type IV (8) - Depressed lesions]

2020-8-10. 8PM. EndoTODAY Live

* Âü°í: In depth analysis º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï À§³»½Ã°æ ¾ÆƲ¶ó½º (PDF) 2024

º¸¸¸ 4Çü ÁøÇ༺À§¾ÏÀÇ ¹Ì¶õÀ̳ª ±Ë¾çÀº ¹«Ã´ ´Ù¾çÇÑ ¸ð½ÀÀ» º¸ÀÔ´Ï´Ù. °£È¤ ù ³»½Ã°æ °Ë»ç¿¡¼­ 1-2cm Å©±âÀÇ ÀÛÀº ÇÔ¸ôÇü À§¾ÏÀ¸·Î ÃßÁ¤ÇÏ¿´À¸³ª, ÃÖÁ¾ °á·ÐÀº 10-15 cm Å©±âÀÇ º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀ¸·Î ³ª¿À´Â ´çȲ½º·¯¿î °æ¿ì°¡ ÀÖ½À´Ï´Ù. (1) ºñ±³Àû ÀþÀº ¿©¼º, (2) À§Ã¼ºÎÀÇ ÇÔ¸ôÇü Á¶±âÀ§¾Ï, (3) poorly differentiated adenocarcinoma ȤÀº signet ring cell carcinomaÀÇ °æ¿ì´Â Ȥ½Ã 'ÀÛÀº ÇÔ¸ôÇü º´¼Ò¸¦ °¡Áö°í ÀÖ´Â Å« º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï'Àº ¾Æ´ÑÁö ´Ã ÁÖÀÇÇսôÙ.


°í·É ¿©¼º (comment: °Ë»çµµ Àß ÇÏ¼Ì°í »çÁøµµ Àß ÂïÀ¸¼Ì´Âµ¥... ³»½Ã°æ »çÁøÀÇ contrast°¡ ³Ê¹« °­ÇÕ´Ï´Ù. Á¶±Ý ³·ÃçÁֽʽÿÀ)

µÎ²¨¿öÁø ÁÖ¸§ÀÌ ¹¶Ãļ­ ÆÇó·³ º¸ÀÌ´Â °¡¿îµ¥ÀÇ ÀÛÀº ¹Ì¶õ

´ëºÎºÐÀº Á¤»óÁ¡¸·ÀÌÁö¸¸ À§Ã¼ÇϺΠ´ë¸¸¿¡ ÀÛÀº ¹Ì¶õÀÌ Çϳª ÀÖÀ½

À§Ã¼»óºÎ ´ë¸¸ÀÇ ÀÛ°í ±íÀº º°¸ð¾çÀÇ ±Ë¾ç

À§Ã¼»óºÎ ´ë¸¸ÀÇ ³Ð°í ¾èÀº ºñ±³Àû µÕ±Ù ±Ë¾ç

À§Ã¼ÇϺΠ¼Ò¸¸ÀÇ ±íÀº ±Ë¾ç

À§Ã¼ÇϺΠ´ë¸¸ÀÇ Å©°í ±íÀº ±Ë¾ç

À§Ã¼»óºÎ ´ë¸¸¿¡¼­ fundus·Î ³Ñ¾î°¡´Â ºÎÀ§(saddle area)ÀÇ ÀÛÀº ±Ë¾ç.

°¡º­¿î ¼ÒÈ­ºÒ·®Áõ ÀÌ¿Ü¿¡ Ưº°ÇÑ Áõ»óÀÌ ¾ø¾ú´ø 40´ë ¿©¼ºÀ¸·Î °Ç°­°ËÁøÀ» ÅëÇÏ¿© ¿ì¿¬È÷ ¹ß°ßµÈ À§¾ÏÀ̾ú½À´Ï´Ù (¸¶Áö¸· ³»½Ã°æ°Ë»ç: 1³â ¹Ý Àü). ³»½Ã°æ¿¡¼­ ÇÑ ´«¿¡ µé¾î¿À´Â º´¼Ò´Â À§°¢ºÎ Àüº®ÂÊÀ¸·Î ÀÛÀº depressed lesionÀ̸ç Àç°Ë¿¡¼­´Â ¾à°£ ´õ Å« ±Ë¾ç¼º º´¼Ò·Î °üÂûµÇ¾ú½À´Ï´Ù (Á¶Á÷°Ë»ç: signet ring cell carcinoma). ù »çÁøÀ» º¸¸é EGC IIc, µÎ¹ø° »çÁøÀ» º¸¸é EGC III ȤÀº AGC Borrmann type II¸¦ ÁÖ¸é Àû´çÇØ º¸ÀÔ´Ï´Ù. ±×·¯³ª ±Ë¾ç ÁÖº¯ÀÌ edematousÇØ º¸ÀÌ´Â °Í¿¡ Á» ´õ ÁÖÀǸ¦ ÇØ º¸½Ê½Ã¿À. ±×¸®°í À§Ã¼ºÎÀÇ ÁÖ¸§ÀÌ ´Ù¼Ò ºÒ±ÔÄ¢ÇÏ°Ô thickened µÇ¾î ÀÖÀ¸¸é¼­ thickened foldÀÇ Á¡¸·ÀÌ hyperemicÇÑ patternÀ» º¸ÀÌ°í ÀÖ´Ù´Â Á¡µµ °£°úÇÏÁö ¸¶½Ã±â ¹Ù¶ø´Ï´Ù.
ºñ·Ï À§Ã¼ºÎ°¡ °ø±â ÁÖÀԽà ¸Å¿ì Àß ÆØâµÇ´Â ¾ç»óÀ̾ú°í À§Ã¼ºÎ¿¡¼­ ¸í¹éÇÑ ±Ë¾ç¼º º´¼Ò³ª Á¾¾ç¼º º´¼Ò°¡ °üÂûµÇÁö ¾Ê¾ÒÁö¸¸, thickened fold¿Í °¡±î¿î ºÎÀ§ÀÇ ÇÔ¸ôÇü º´¼Ò¿¡¼­ signet ring cellÀÌ ³ª¿Ô´Ù´Â Á¡°ú ÀþÀº ¿©¼ºÀ̾ú´Ù´Â Á¡À» °í·ÁÇϸé À§Ã¼ºÎÀÇ ¼Ò°ßÀº Borrmann type IV¸¦ ÀǽÉÄÉ ÇÏ´Â °ÍÀ¸·Î Çؼ®ÇÏ´Â °ÍÀÌ ÁÁÀ» µí ½Í½À´Ï´Ù. ¹°·Ð ÀÌ·± ȯÀÚ(¾ÏÀ¸·Î È®ÀÎµÈ ÀÛÀº ÇÔ¸ôÇü º´¼Ò°¡ ÀÖ°í ÁÖº¯Àº Å©°Ô ÀÌ»óÇØ º¸ÀÌÁö ¾Ê´Â °æ¿ì)¸¦ ¼ö¼ú Àü¿¡ ¸Å¿ì Å« Borrmann type IV·Î Áø´ÜÇÏ´Â °ÍÀº ½¬¿î ÀÏÀº ¾Æ´Õ´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ È¯ÀÚµµ ÀÖ´Ù´Â Á¡À» ÀØÁö ¾Ê°í °Ë»çÇϴ ŵµ°¡ ¹Ù¶÷Á÷ÇÒ °ÍÀÔ´Ï´Ù. ÀÌ È¯ÀÚÀÇ ÃÖÁ¾ pathology´Â ´ÙÀ½°ú °°¾Ò½À´Ï´Ù. Signet-ring cell carcinoma, 17x15 cm, extension to subserosa, LN 17/35, perineural invasion (+)


2013³â Áõ·ÊÀÔ´Ï´Ù. ÀÛÀº À§¾ÏÀ¸·Î ÆÇ´ÜÇÏ¿© º¹°­°æ ¼ö¼úÀ» À§ÇØ mini-laparotomy ÈÄ º´¼Ò È®ÀÎÇÑ ¹Ù MB, PW¿¡ palpable mass°¡ ÀÖ´Â Borrmann type ¥³ AGC·Î ÆǴܵǾî LATG ½ÃÇàÇÏ¿´½À´Ï´Ù.


Stomach, radical total gastrectomy:
Advanced gastric carcinoma
1. Location : upper third, middle third, lower third, Center at body and greater curvature, posterior wall
2. Gross type : Borrmann type 4 (mimicking EGC type IIa+IIc)
3. Histologic type : tubular adenocarcinoma, poorly (poorly cohesive) differentiated
4. Histologic type by Lauren : diffuse
5. Size : 15.2x7.4 cm
6. Depth of invasion : invades serosa (pT4a)
7. Resection margin: free from carcinoma, safety margin: proximal 1.1 cm, distal 7.6 cm
8. Lymph node metastasis : no metastasis in 33 regional lymph nodes (pN0)
9. Lymphatic invasion : present
10. Venous invasion : present(intramural)
11. Perineural invasion : present
12. AJCC stage by 7th edition: pT4a N0


À§Ã¼»óºÎ Àüº®ÀÇ ÀÛÀº ±Ë¾çÇü À§¾Ï(poorly differentiated adenocarcinoma)À¸·Î ÀÇ·ÚµÈ 50´ë ¿©¼ºÀÔ´Ï´Ù. ȯÀÚÀÇ ¼ºº°°ú ³ªÀÌ, ¼¼Æ÷Çü, º´¼ÒÀÇ À§Ä¡, ÁÖº¯ Á¡¸·ÀÌ ¾à°£ µÎ²¨¿î Á¡À» °í·ÁÇÏ¿© º¸¸¸ 4Çü ÁøÇü¼º À§¾ÏÀÇ °¡´É¼ºÀ» °í·ÁÇÏ¿´½À´Ï´Ù. ³»½Ã°æ °Ë»ç ÀǷڽà "ÀÛÀº ÇÔ¸ôÇü À§¾ÏÀ¸·Î ¿À¼Ì½À´Ï´Ù. ±×·¯³ª ÁÖº¯ À§º®À̳ª fold°¡ µÎ²¨¿öÁø ºÎÀ§´Â ¾ø´ÂÁö Àß »ìÆìºÁ ÁÖ¼¼¿ä."¶ó°í ºÎŹÇÏ¿´½À´Ï´Ù. ¾Æ´Ï³ª ´Ù¸¦±î º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀ¸·Î ³ª¿Ô½À´Ï´Ù.


Stomach, total gastrectomy:
Advanced gastric carcinoma1. Location : [1] upper third, [2] middle third, Center at body and anterior wall
2. Gross type : Borrmann type 4
3. Histologic type : tubular adenocarcinoma, poorly (poorly cohesive) differentiated
4. Histologic type by Lauren : diffuse
5. Size : about 9.5x7 cm
6. Depth of invasion : invades serosa (pT4a)
7. Resection margin: free from carcinoma
8. Lymph node metastasis : metastasis to 1 out of 28 regional lymph nodes (pN1) (isolated tumor cells, about 0.1 mm), (perinodal extension: absent), (1/28: "2", 0/1; "3", 0/6; "4", 0/0; "5", 0/6; "6", 1/1; "7", 0/3; "9", 0/1; "8a", 0/4; "11p", 0/1; "12a", 0/2; "4sb", 0/0; "1", 0/1; perigastric, 0/2)
9. Lymphatic invasion : present
10. Venous invasion : not identified
11. Perineural invasion : present

¼ö¼ú °á°ú¸¦ º¸°í °Ë»ç¸¦ Çϼ̴ø fellow ¼±»ý´Ô²²¼­ "±³¼ö´Ô. ¿ª½Ã Á³½À´Ï´Ù."¶ó´Â Á¦¸ñÀÇ ¸ÞÀÏÀ» º¸³»¿À¼Ì½À´Ï´Ù.^^ "¾È³çÇϼ¼¿ä. Àú¹ø¿¡ ¸ÞÀÏÁ̴ּø ±× ȯÀÚºÐÀÔ´Ï´Ù! ¸ðó·³ ¸¸³­ º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀ̾ú½À´Ï´Ù. À§ÁÖ¸§ÀÇ º¯È­°¡ ±×¸® ½ÉÇÏÁö ¾Ê´Ù°í »ý°¢Çߴµ¥... ¼ö¼ú°á°ú´Â 10cm Å©±â·Î ³ª¿Ô½À´Ï´Ù. »çÁøÀ» ´Ù½Ã º¸´Ï, ¾à°£ Àǽɽº·¯¿î fold°¡ ´õ ¸Ö¸®±îÁö º¸ÀÌ´Â °Í °°½À´Ï´Ù."

Á¦°¡ ´äÀåÀ» º¸³Â½À´Ï´Ù. "º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀº ´Ã ¾î·Æ½À´Ï´Ù. (1) ¿©¼º, (2) À§Ã¼ºÎ, (3) ÀüÇüÀûÀÎ EGC¿Í´Â ´Ù¸¥ °æ°è°¡ ¸íÈ®ÇÏÁö ¾ÊÀº ÀÛÀº ÇÔ¸ôÇü º´¼Ò, (4) P/D ¶Ç´Â SRC¿¡¼­´Â º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀε¥ ÀÛÀº ÇÔ¸ôÇü º´¼Ò·Î¸¸ °üÂûµÇ´Â °æ¿ì'¸¦ ÀǽÉÇØ¾ß ÇÕ´Ï´Ù. ÀÌ È¯ÀÚ´Â 4°¡Áö ¸ðµÎ ÇØ´çÇÏ¿´½À´Ï´Ù. ³»½Ã°æ ¼Ò°ßÀ¸·Î º´¼ÒÀÇ Å©±â¿Í ±íÀ̸¦ ÁüÀÛÇÏ´Â °Íµµ ÁÁÁö¸¸ ÀÓ»ó»óµµ ÀØÁö ¸»¾ÆÁÖ¼¼¿ä."

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.